|
|
The Amorphous Pharmaceutical Material 2010 conference is the most remarkable event of Pharmaceutical industry that intends to bring together leading industry experts to review methodologies, emerging applications techniques and challenges. The two-day conference will serve as a wonderful platform for the attendees, as they will be able to explore newest products, strategies as well as technology and also numerous networking opportunities with leaders from pharma-biotech, healthcare and regulatory agencies. The conference consists of presentation on the approaches to amorphous detection, interactive panel discussion and case studies ranging from amorphous formulation to novel amorphous micro particle technology.
Key topics to be discussed at Amorphous Pharmaceutical Material 2010 are:
-
Strategies to protect and commercialize innovations in amorphous materials
-
Patents - amorphous materials & formulations
-
Amorphisation as tool for product life cycle management
-
Stable amorphous dispersions – science, formulation and manufacturing method
-
Amorphous food materials – Some lessons from food research
-
Biopharmaceutical implications for development of amorphous solid solution intermediates
-
Approach to amorphous detection and quantization within GSK
-
Amorphous content: Quantification in drug substance and drug product
-
Partially amorphous materials: In-situ monitoring of the recrystallisation process at the nanoscale using heated tip AFM
-
Automated solid dispersion screening: A useful tool to design amorphous systems
-
Stability assessment of amorphous pharmaceuticals with calorimetry
-
Developing solid dispersions by spray drying
-
Process analytical techniques during amorphisation by hot melt extrusion
Visitor Profile
- Business Development
- Product Design
- Particle Engineering
- Drug Discovery
- Solid State Chemistry
- API Development
- Crystallization
- Stability / Stability testing
- Research and Development
- Technical Operations
- Manufacturing Science
- Regulatory affairs
Organizer
Visiongain Ltd.
